Gestational diabetes and fetal overgrowth: time to rethink screening guidelines

Affiliations

¹ Department of Health Sciences, University Magna Græcia of Catanzaro, Catanzaro 88100, Italy.
² Operative Unit of Gynecology and Obstetrics, Hospital Pugliese-Ciaccio, Catanzaro, Italy.
³ Department of Health Sciences, University Magna Græcia of Catanzaro, Catanzaro 88100, Italy. Electronic address: brunetti@unicz.it.

Comment

Eusebio Chiefari et al. Lancet Diabetes Endocrinol. 2020 Jul.

. 2020 Jul;8(7):561-562.

doi: 10.1016/S2213-8587(20)30189-3.

¹ Department of Health Sciences, University Magna Græcia of Catanzaro, Catanzaro 88100, Italy.
² Operative Unit of Gynecology and Obstetrics, Hospital Pugliese-Ciaccio, Catanzaro, Italy.
³ Department of Health Sciences, University Magna Græcia of Catanzaro, Catanzaro 88100, Italy. Electronic address: brunetti@unicz.it.

No abstract available

Comment on

Glycaemic status during pregnancy and longitudinal measures of fetal growth in a multi-racial US population: a prospective cohort study.
Li M, Hinkle SN, Grantz KL, Kim S, Grewal J, Grobman WA, Skupski DW, Newman RB, Chien EK, Sciscione A, Zork N, Wing DA, Nageotte M, Tekola-Ayele F, Louis GMB, Albert PS, Zhang C. Li M, et al. Lancet Diabetes Endocrinol. 2020 Apr;8(4):292-300. doi: 10.1016/S2213-8587(20)30024-3. Epub 2020 Mar 2. Lancet Diabetes Endocrinol. 2020. PMID: 32135135 Free PMC article.